Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
2.
Article in English | MEDLINE | ID: mdl-38562514

ABSTRACT

We assessed the impact of metagenomic next-generation sequencing (mNGS) on patient care using previously established criteria. Among 37 patients receiving mNGS testing, 16% showed results that had a positive clinical impact. While mNGS results may offer valuable supplementary information, results should be interpreted within the broader clinical context and evaluation.

3.
Article in English | MEDLINE | ID: mdl-38156230

ABSTRACT

Chat Generative Pre-trained Transformer (ChatGPT), the flagship generative artificial intelligence (AI) chatbot by OpenAI, is transforming many things in medicine, from healthcare and research to medical education. It is anticipated to integrate in many aspects of the medical industry, and we should brace for this inevitability and use it to our advantage. Here are proposed ways you can use ChatGPT in medicine with some specific use cases in antimicrobial stewardship and hospital epidemiology.

5.
Gastroenterol Clin North Am ; 50(2): 415-430, 2021 06.
Article in English | MEDLINE | ID: mdl-34024449

ABSTRACT

Infectious gastroenteritis is common after transplantation and can lead to increased morbidity and mortality. A wide range of organisms can lead to gastroenteritis in this patient population. Clostridioides difficile, cytomegalovirus, and norovirus are the most common pathogens. Newer diagnostic methods, especially multiplex polymerase chain reaction, have increased the diagnostic yield of infectious etiologies. In this review, we describe the epidemiology and risk factors for common infectious pathogens leading to gastroenteritis.


Subject(s)
Gastroenteritis , Hematopoietic Stem Cell Transplantation , Norovirus , Organ Transplantation , Diarrhea , Gastroenteritis/diagnosis , Gastroenteritis/epidemiology , Gastroenteritis/etiology , Humans , Norovirus/genetics , Organ Transplantation/adverse effects
8.
Transl Res ; 183: 41-56, 2017 05.
Article in English | MEDLINE | ID: mdl-28068521

ABSTRACT

Antiretroviral therapy has revolutionized the care of people with human immunodeficiency virus (HIV) by reducing morbidity and mortality from acquired immunodeficiency syndrome-related conditions. Despite longer life expectancy, however, HIV-infected individuals continue to have a higher risk of death compared with the general population. This has been attributed to the increasing incidence of noncommunicable diseases, in particular, atherosclerotic cardiovascular diseases. This is driven, in part, by the emergence of metabolic disorders, particularly dyslipidemia, insulin resistance, and lipodystrophy, in those on antiretroviral therapy. The pathogenesis of these metabolic derangements is complex and multifactorial, and could be a consequence of an interplay between traditional age-related risk factors, HIV infection, antiretroviral therapy effects, and the inflammatory state and immune activation in this population. Understanding the contributions of each of these factors could not just impact the current management of these individuals and help mitigate the risk for premature cardiovascular disease, but also shape the future direction of research in HIV.


Subject(s)
Dyslipidemias/etiology , HIV Infections/complications , Insulin Resistance/physiology , Anti-HIV Agents/adverse effects , Anti-HIV Agents/classification , Anti-HIV Agents/pharmacology , Dyslipidemias/prevention & control , HIV Infections/epidemiology , HIV Infections/immunology , HIV Infections/virology , Humans
9.
Transpl Infect Dis ; 19(2)2017 Apr.
Article in English | MEDLINE | ID: mdl-28099778

ABSTRACT

Non-Candida opportunistic yeasts are emerging causes of bloodstream infection (BSI) in immunocompromised hosts. However, their clinical presentation, management, and outcomes in stem cell transplant (SCT) recipients are not well described. We report the first case to our knowledge of Pseudozyma BSI in a SCT recipient. He had evidence of cutaneous involvement, which has not been previously described in the literature. He became infected while neutropenic and receiving empiric micafungin, which is notable because Pseudozyma is reported to be resistant to echinocandins. He was successfully treated with the sequential use of liposomal amphotericin B and voriconazole. A review of the literature revealed nine reported instances of Pseudozyma fungemia. We performed a retrospective review of 3557 SCT recipients at our institution from January 2000 to June 2015 and identified four additional cases of non-Candida yeast BSIs. These include two with Cryptococcus, one with Trichosporon, and one with Saccharomyces. Pseudozyma and other non-Candida yeasts are emerging pathogens that can cause severe and disseminated infections in SCT recipients and other immunocompromised hosts. Clinicians should have a high degree of suspicion for echinocandin-resistant yeasts, if patients develop breakthrough yeast BSIs while receiving echinocandin therapy.


Subject(s)
Antifungal Agents/therapeutic use , Dermatomycoses/microbiology , Exanthema/microbiology , Fungemia/microbiology , Opportunistic Infections/microbiology , Ustilaginales/pathogenicity , Yeasts/pathogenicity , Adult , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antifungal Agents/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Cryptococcus/isolation & purification , Cryptococcus/pathogenicity , Cytarabine/therapeutic use , Dermatomycoses/blood , Dermatomycoses/drug therapy , Dermatomycoses/pathology , Echinocandins/administration & dosage , Echinocandins/therapeutic use , Exanthema/blood , Exanthema/drug therapy , Exanthema/pathology , Fever/microbiology , Fungemia/drug therapy , Granulocyte Colony-Stimulating Factor/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Idarubicin/therapeutic use , Immunocompromised Host , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy , Lipopeptides/administration & dosage , Lipopeptides/therapeutic use , Male , Micafungin , Opportunistic Infections/blood , Opportunistic Infections/drug therapy , Retrospective Studies , Saccharomyces/isolation & purification , Saccharomyces/pathogenicity , Salvage Therapy/methods , Trichosporon/isolation & purification , Trichosporon/pathogenicity , Ustilaginales/isolation & purification , Vidarabine/analogs & derivatives , Vidarabine/therapeutic use , Voriconazole/administration & dosage , Voriconazole/therapeutic use , Yeasts/isolation & purification
10.
J Infect ; 74(2): 179-186, 2017 02.
Article in English | MEDLINE | ID: mdl-27777118

ABSTRACT

BACKGROUND: Staphylococcus lugdunensis is a coagulase-negative staphylococcus with similar virulence characteristics as Staphylococcus aureus. Whether S. lugdunensis causes infective endocarditis (IE) in a similar proportion of cases as S. aureus (reported to be 12.6% in a definitive multicenter prospective study) is unclear. METHODS: We conducted a retrospective cohort study of adult patients with at least one blood culture positive for S. lugdunensis at our institution from January 2006 to December 2014. We examined microbiology data, ascertained disease severity and determined the proportion of patients with definite or possible IE based on the 2000 Modified Duke Criteria. Because coagulase-negative staphylococci were routinely identified to the species level at our institution from 2012 onwards, we determined the proportion of patients with definite or possible IE before and after implementation of routine speciation. We also compared our results with reported proportions of IE among patients with S. lugdunensis bacteremia (SLB) in other institutions by conducting a systematic review of the scientific literature. Nonparametric bootstrapping methods were performed to determine 95% confidence intervals (CI) for proportions of IE in patients with SLB. RESULTS: Seventy-four patients with SLB were identified, of whom 64% (47/74) had sepsis by SIRS criteria, and 18% (13/74) had severe illness by Pittsburgh bacteremia score (PBS). Kaplan-Meier survival analysis showed that one-year survival among patients with severe illness was worse than patients with non-severe illness (p = 0.02). Fifteen percent (11/74) of patients had definite or possible IE (95% CI 6.8-23.0%). The proportion of SLB patients with definite or possible IE was 15.8% (6/38, 95% CI 5.3-28.9%) prior to routine speciation and 13.9% (5/36, 95% CI 2.8-27.8%) after routine speciation (p = 0.71). Among patients with at least two positive blood cultures for S. lugdunensis, 25% (10/40, 95% CI 12.5-40.0%) had IE. Systematic review of the literature yielded eight relevant retrospective studies. Of studies that included patients with one or more positive blood cultures for S. lugdunensis, the proportion of IE ranged from 6.3% to 27.0%. CONCLUSION: The proportion of definite or possible IE among patients with SLB is similar to the proportion of IE among patients with S. aureus bacteremia. The proportions of IE among patients with SLB at other institutions fall within the 95% CI yielded by bootstrapping. Our findings suggest that growth of S. lugdunensis in two separate blood cultures should prompt consideration of workup for IE.


Subject(s)
Bacteremia/microbiology , Endocarditis, Bacterial/epidemiology , Endocarditis, Bacterial/microbiology , Staphylococcal Infections/microbiology , Staphylococcus lugdunensis/isolation & purification , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/mortality , Cohort Studies , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/mortality , Female , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcal Infections/mortality , Staphylococcus lugdunensis/pathogenicity , United States/epidemiology , Young Adult
11.
Antivir Ther ; 21(4): 365-7, 2016.
Article in English | MEDLINE | ID: mdl-26555254

ABSTRACT

Retinal toxicity involving the macula as a complication of the antiretroviral protease inhibitor ritonavir has been described in a few cases. We report retinal pigment epitheliopathy involving the macula with a bull's eye pattern in a 36-year-old man with well-controlled HIV receiving ritonavir with gradually progressive bilateral vision loss.


Subject(s)
Anti-HIV Agents/adverse effects , Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Macular Degeneration/chemically induced , Ritonavir/adverse effects , Ritonavir/therapeutic use , Adult , Anti-HIV Agents/administration & dosage , Drug Administration Schedule , Humans , Male , Ritonavir/administration & dosage
13.
Am J Trop Med Hyg ; 93(5): 1068-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26324725

ABSTRACT

Hemophagocytic lymphohistiocytosis (HLH) and rhabdomyolysis are rare complications of typhoid fever from Salmonella enterica serovar Typhi. Herein, we describe the clinical features in a 21-year-old female from India who presented to the intensive care unit with fever, severe pancytopenia, and rhabdomyolysis.


Subject(s)
Lymphohistiocytosis, Hemophagocytic/complications , Rhabdomyolysis/complications , Salmonella typhi/isolation & purification , Typhoid Fever/complications , Disk Diffusion Antimicrobial Tests , Drug Combinations , Drug Resistance, Bacterial , Drug Therapy, Combination , Female , Fever , Humans , India , Lymphohistiocytosis, Hemophagocytic/drug therapy , Rhabdomyolysis/drug therapy , Salmonella typhi/drug effects , Sepsis , Sulfamethizole/therapeutic use , Treatment Outcome , Trimethoprim/therapeutic use , Typhoid Fever/drug therapy , Young Adult
14.
BMJ Case Rep ; 20152015 Mar 30.
Article in English | MEDLINE | ID: mdl-25824286

ABSTRACT

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is a rare cause of necrotising fasciitis (NF), and is usually not fulminant as in group A Streptococcus (GAS), the archetypal aetiology. We report an unusually fulminant case of NF by CA-MRSA in an immunocompetent patient. A 52-year-old man presented to the emergency department with 1 week of progressive left thigh pain and swelling. The patient had ecchymoses, bullae and hypoesthesia of the involved skin, and CT scan revealed extensive fascial oedema. He was immediately started on broad spectrum antibiotics. Within 12 h of presentation, he underwent surgical debridement. Despite aggressive supportive care, the patient died less than 24 h after presentation. MRSA, with an antibiogram suggestive of a community-acquired strain, was recovered from intraoperative specimens and admission blood cultures. This case underscores that CA-MRSA, while rarely reported, can cause a fulminant presentation of NF similar to GAS in immunocompetent patients.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacteremia/microbiology , Fasciitis, Necrotizing/diagnosis , Fasciitis, Necrotizing/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/diagnosis , Thigh/pathology , Bacteremia/diagnosis , Community-Acquired Infections/diagnosis , Community-Acquired Infections/microbiology , Debridement , Fatal Outcome , Humans , Male , Middle Aged , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathology , Thigh/microbiology
15.
Anaerobe ; 34: 84-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25881498

ABSTRACT

We report two cases of bacteremia with Actinobaculum schaalii, a rarely reported, anaerobic, Gram-positive bacterium. The first case was a patient with renal cancer who developed pyelonephritis after cryoablation, and the second was a patient who developed sepsis after a urogenital procedure. Bacteremia resolved after administration of empiric antibiotic therapy.


Subject(s)
Actinomycetaceae/isolation & purification , Actinomycetales Infections/diagnosis , Actinomycetales Infections/pathology , Bacteremia/diagnosis , Bacteremia/pathology , Actinomycetaceae/classification , Actinomycetales Infections/drug therapy , Actinomycetales Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Bacteria, Anaerobic/classification , Bacteria, Anaerobic/isolation & purification , Female , Humans , Male , Middle Aged , Treatment Outcome
16.
BMJ Case Rep ; 20152015 Jan 22.
Article in English | MEDLINE | ID: mdl-25612752

ABSTRACT

Central diabetes insipidus (CDI) is an infrequent complication of neurosarcoidosis (NS). Its presentation may be masked by adrenal insufficiency (AI) and uncovered by subsequent steroid replacement. A 45-year-old woman with a history of NS presented 2 weeks after abrupt cessation of prednisone with nausea, vomiting, decreased oral intake and confusion. She was diagnosed with secondary AI and intravenous hydrocortisone was promptly begun. Over the next few days, however, the patient developed severe thirst and polyuria exceeding 6 L of urine per day, accompanied by hypernatraemia and hypo-osmolar urine. She was presumed to have CDI due to NS, and intranasal desmopressin was administered. This eventually normalised her urine output and serum sodium. The patient was discharged improved on intranasal desmopressin and oral prednisone. AI may mask the manifestation of CDI because low serum cortisol impairs renal-free water clearance. Steroid replacement reverses this process and unmasks an underlying CDI.


Subject(s)
Adrenal Insufficiency/diagnosis , Central Nervous System Diseases/complications , Diabetes Insipidus, Neurogenic/diagnosis , Sarcoidosis/complications , Adrenal Insufficiency/drug therapy , Antidiuretic Agents/therapeutic use , Deamino Arginine Vasopressin/therapeutic use , Diabetes Insipidus, Neurogenic/drug therapy , Diabetes Insipidus, Neurogenic/etiology , Female , Glucocorticoids/therapeutic use , Humans , Hydrocortisone/blood , Hypernatremia/diagnosis , Hypernatremia/drug therapy , Hypernatremia/etiology , Middle Aged , Polyuria/diagnosis , Polyuria/drug therapy , Polyuria/etiology , Prednisone/therapeutic use , Thirst
17.
BMJ Case Rep ; 20142014 Nov 12.
Article in English | MEDLINE | ID: mdl-25391828

ABSTRACT

Mucormycosis is rare, presenting as breakthrough infection among haematological and transplant patients on prophylaxis with voriconazole. We report an unusual presentation of this infection, that which is pneumonia progressing to cardiac arrest. A 68-year-old woman with refractory acute myelogenous leukaemia on voriconazole prophylaxis was initially admitted for neutropenic fever and pneumonia. She was discharged improved on antibiotics and voriconazole for presumed aspergillosis. She returned after 1 month with the same presentation. She eventually improved on antibiotics and voriconazole, and eventually received bone marrow transplantation. Three days later, she developed pleuritic chest pain, dyspnoea, and hypoxia requiring intubation. An hour after intubation, the patient arrested and expired. Autopsy revealed Rhizopus pneumonitis with pulmonary infarction, and emboli to her cerebellum, heart, thyroid and kidney. Mucormycosis is an emerging, fatal infection that should be suspected in haematological and transplant patients who deteriorate on voriconazole.


Subject(s)
Bone Marrow Transplantation/adverse effects , Death, Sudden , Leukemia, Myeloid, Acute/surgery , Lung Diseases, Fungal/diagnosis , Mucormycosis/diagnosis , Aged , Biopsy, Needle , Bone Marrow Transplantation/methods , Disease Progression , Female , Humans , Immunohistochemistry , Leukemia, Myeloid, Acute/diagnosis , Leukemia, Myeloid, Acute/drug therapy , Lung Diseases, Fungal/drug therapy , Mucormycosis/drug therapy , Postoperative Complications/diagnosis , Postoperative Complications/drug therapy , Postoperative Complications/microbiology , Tomography, X-Ray Computed/methods
18.
PLoS One ; 9(9): e107677, 2014.
Article in English | MEDLINE | ID: mdl-25232729

ABSTRACT

OBJECTIVES: MET is a receptor present in the membrane of NSCLC cells and is known to promote cell proliferation, survival and migration. MET gene copy number is a common genetic alteration and inhibition o MET emerges as a promising targeted therapy in NSCLC. Here we aim to combine in a meta-analysis, data on the effect of high MET gene copy number on the overall survival of patients with resected NSCLC. METHODS: Two independent investigators applied parallel search strategies with the terms "MET AND lung cancer", "MET AND NSCLC", "MET gene copy number AND prognosis" in PubMed through January 2014. We selected the studies that investigated the association of MET gene copy number with survival, in patients who received surgery. RESULTS: Among 1096 titles that were identified in the initial search, we retrieved 9 studies on retrospective cohorts with adequate retrievable data regarding the prognostic impact of MET gene copy number on the survival of patients with NSCLC. Out of those, 6 used FISH and the remaining 3 used RT PCR to assess the MET gene copy number in the primary tumor. We calculated the I2 statistic to assess heterogeneity (I2 = 72%). MET gene copy number predicted worse overall survival when all studies were combined in a random effects model (HR = 1.78, 95% CI 1.22-2.60). When only the studies that had at least 50% of adenocarcinoma patients in their populations were included, the effect was significant (five studies, HR 1.55, 95% CI 1.23-1.94). This was not true when we included only the studies with no more than 50% of the patients having adenocarcinoma histology (four studies HR 2.18, 95% CI 0.97-4.90). CONCLUSIONS: Higher MET gene copy number in the primary tumor at the time of diagnosis predicts worse outcome in patients with NSCLC. This prognostic impact may be adenocarcinoma histology specific.


Subject(s)
Carcinoma, Non-Small-Cell Lung/mortality , Gene Dosage/genetics , Lung Neoplasms/mortality , Proto-Oncogene Proteins c-met/genetics , Anaplastic Lymphoma Kinase , Carcinoma, Non-Small-Cell Lung/genetics , ErbB Receptors/genetics , Humans , Lung Neoplasms/genetics , Protein-Tyrosine Kinases/genetics , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Retrospective Studies , Survival Analysis , Treatment Outcome
19.
Acta Medica Philippina ; : 67-71, 2010.
Article in English | WPRIM (Western Pacific) | ID: wpr-632904

ABSTRACT

The imbricata or Tokelau ringworm is an unusual superficial dermatophytosis caused by the anthropophilic Trichophyton concentricum. Three cases of the Tinea imbricata observed at the Municipal Health Office of Kiamba, Sarangani Province, Philippines are reported in this study. All three patients were from an indigenous ethnic group of Sarangani Province and lived in isolated upland communities. Patient 1 was a 30 year old male, Patient 2 was a 40 year old female, and Patient 3 was a 19 year old female. Lesions lasted - 27 years, - 25 years, and 2 years, respectively. All patients presented with characteristic expensive polycyclic to serpiginous scaling lesions, with areas of sparing. Microscopic examination of skin scrapings prepared with potassium hydroxide revealed the characteristic broad, branched, septate, irregular hyphae. Trichopyton concentricum, the causative agent, was isolated in one of the patients using Mycobiotoc agar. Histopathologic examination on 2 of the patients revealed acute and chronic inflammation, and Periodic Acid Schiff- positive fungal hyphae. All patients were started on Griseofulvin 500mg tab once daily. The case series presented here is the first account of Tinea imbricata in the Philippines since the 1990s.


Subject(s)
Humans , Male , Female , Adult , Agar , Ethnicity , Griseofulvin , Hydroxides , Hyphae , Inflammation , Periodic Acid , Philippines , Polynesia , Potassium Compounds , Skin , Tinea , Trichophyton , Tinea Capitis
SELECTION OF CITATIONS
SEARCH DETAIL
...